North American regulatory agencies can and should make clinical trial data publicly available.
about
Secrecy or transparency? The future of regulatory trial data.Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports.Informed Consent to Study Purpose in Randomized Clinical Trials of Antibiotics, 1991 Through 2011.Increasing the transparency of clinical data.ClinicalTrials.gov for Facilitating Rapid Understanding of Potential Harms of New Drugs: The Case of Checkpoint Inhibitors.
P2860
North American regulatory agencies can and should make clinical trial data publicly available.
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
North American regulatory agen ...... trial data publicly available.
@ast
North American regulatory agen ...... trial data publicly available.
@en
type
label
North American regulatory agen ...... trial data publicly available.
@ast
North American regulatory agen ...... trial data publicly available.
@en
prefLabel
North American regulatory agen ...... trial data publicly available.
@ast
North American regulatory agen ...... trial data publicly available.
@en
P2860
P356
P1476
North American regulatory agen ...... trial data publicly available.
@en
P2093
Nav Persaud
Peter Doshi
P2860
P356
10.1503/CMAJ.150679
P407
P577
2015-10-13T00:00:00Z